Meditations on secondary revascularisation in the aftermath of the SYNTAX trial

EuroIntervention

Volumn 5, Issue SUPPL. D, 2009, Pages

  Garg, Scot ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Secondary coronary revascularisation; Severe coronary artery disease; SYNTAX trial

Indexed keywords

'TAXUS'; PACLITAXEL; UNCLASSIFIED DRUG;

ARTICLE; BARE METAL STENT; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DECISION MAKING; DRUG ELUTING STENT; EVENT FREE SURVIVAL; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; SAPHENOUS VEIN GRAFT; SECONDARY HEART MUSCLE REVASCULARIZATION; TREATMENT INDICATION; TREND STUDY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE;

EID: 77951297132     PISSN: 1774024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Boden, WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS. Optical medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356(15):1503-16.
2. Chaitman BR, Ryan TJ, Kronmal RA, Foster ED, Frommer PL, Killip T. Coronary Artery Surgery Study (CASS): comparability of 10 year survival in randomized and randomizable patients. J Am Coll Cardiol 1990;16(5):1071-8.
3. Jones RH, Kesler K, Phillips HR, 3rd, Mark DB, Smith PK, Nelson CL, Newman MF, Reves JG, Anderson RW, Califf RM. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg 1996;111(5):1013-25.
4. Hannan EL, Racz MJ, McCallister BD, Ryan TJ, Arani DT, Isom OW, Jones RH. A comparsiion of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1993;33(1):63-72.
5. Karthik S, Fabri BM. Left internal mammary artery usage in coronary artery bypass grafting: a measure of quality control. Ann R Coll Surg Engl 2006;88(4):367-9.
6. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with internal-thoracic-artery grafts - effects on survival over a 15-year period. N Engl J Med 1996;334(4):216-9.
7. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, Golding LA, Gill CC, Taylor PC, Sheldon WC, Proudfit WL. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986;314(1):1-6.
8. Kapoor JR, Gienger AL, Ardehali R, Varghese R, Perez MV, Sundaram V, McDonald KM, Owens DK, Hlatky MA, Bravata DM. Isolated Disease of the Proximal Left Anterior Descending Artery: Comparing the Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Surgery. J Am Coll Cardiol Intv 2008;1(5):483-491.
9. Ariz O, Rao C, Panesar SS, Jones C, Morris S, Darzi A, Athanasiou T. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery. BMJ 2007;334(7594):617.
10. Goy JJ, Kaufmann U, Hurni M, Cook S, Versaci F, Ruchat P, Bertel O, Pieper M, Meier B, Chiarello L. 10-Year Follow-Up of a Prospective Randomized Trial Comparing Bare-Metal Stenting With Internal Mammary Artery Grafting for Proximal, Isolated De Novo Left Anterior Coronary Artery Stenosis: The SIMA (Stenting versus Internal Mammary Argery grafting) Trial. Journal of the American College of Cardiology 2008;52(10):815.
11. Moreno R, Perez-Rodriguez J, Perez MJ, Alfonso F, Hernandez R, Angiolillo D, Sabate M, Banuelos C, Escaned J, Azcona L, Macaya C. Long-term outcome of patients with proximal left anterior descending coronary artery in-stent restenosis treated with a second percutaneous procedure. J Invasive Cardiol 2005;17(4):218-21.
12. Dimas AP, Arora RR, Whitlow PL, Hollman JL, Franco I, Raymond RE, Dorosti K, Simpfendorfer CC. Percutaneous transluminal angioplasty involving internal mammary artery grafts. Am Heart J 1991;122(2):423-9.
13. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, Buller N, Bonser R, van den Brand MJ, van Herwerden LA, Morel MA, van Hout BA. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344(15):1117-24.
14. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel MA for the BENESTENT Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331(8):489-95.
15. Daemen J, Ong AT, Stefanini GG, Tsuchida K, Spindler H, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW. Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Am J Cardiol 2006;98(7):895-901.
16. Daemen J, Serruys PW. Optimal revascularisation strategies for multivessel coronary artery disease. Curr Opin Cardiol 2006;21(6):595-601.
17. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. Jama 2005;294(10)1215-23.
18. Sim I, Gupta M, McDonald K, Bourassa MG, Hlatky MA. A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasy in multivessel coronary artery disease. Am J Cardiol 1995;76(14):1025-9.
19. Mercado N, Wijn W, Serruys PW, Sigwart U, Flather MD, Stables RH, O'Neill WW, Rodriguez A, Lemos PA, Hueb WA, Gersh BJ, Booth J, Boersma E. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 2005;130(2):512-9.
20. Daemen J, Kuck KH, Macaya C, LeGrand V, Vrolix M, Carrie D, Sheiban I, Suttorp MJ, Vranckx P, Rademaker T, Goedhart D, Schuijer M, Wittebols K, Macours N, Stoll HP, Serruys PW. Multivessel coronary revascularization in patients with and without diabetes mellitus 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. J Am Coll Cardiol 2008;52(24):1957-67.
21. Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb WA, Lemos PA, Serruys PW. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data fro the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008;118(11):1146-54.
22. Daemen J, Serruys PW. Lessons from the Unrestricted Use of Drug-Eluting Stents: Insights from the RESEARCH and T-SEARCH Registry. Indian Heart J 2006;58(1):10-4.
23. Serruys PW, Ong ATL, Morice MC, De Bruyne B, Colombo A, Macaya C, Richard G, Fajadet J, Hamm C, Dawkins K. Arterial Revascularisation Therapies Study Part II-Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroInterv. 2005;1(2):147-156.
24. Pocock SJ, Henderson RA, Rickards AF, Hampton JR, King SB, 3rd, Hamm CW, Puel J, Hueb W, Goy JJ, Rodriguez A. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346(8984):1184-9.
25. Kappetein AP, Dawkins KD, Mohr FW, Morice MC, Mack MJ, Russell ME, Pomar J, Serruys PW. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase Eur J Cardiothorac Surg 2009;29(4):486-91.
26. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). CABRI Trial Participants. Lancet 1995;346(8984):1179-84.
27. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. N Engl J Med. 2009;Mar 5;360(10):961-72.
28. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr F. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroInterv. 2005;1:219-227.
29. Topaz O. Stenting in patients with depressed LVEF: Expanding the territorial boundaries of PCI. Catheter Cardiovasc Interv. 2003;59(4):434-435.
30. Ludman P. BCIS Audit Returns Adult Interventional Procedures Jan 2007 - Dec 2007. http://www.bcis.org.uk/resources/audit_2007 Accessed 15th February 2009.